
Now available Control-IQ+ Technology
The t:slim X2 insulin pump, now powered by Control-IQ+ technology, is the all-in-one system that features a slim, sleek, user-friendly colour touchscreen and seamless integration with Dexcom G7 CGM.*

Tighter Control
Control-IQ+ predicts sensor glucose levels 30 minutes ahead and automatically adjusts or suspends insulin every five minutes.
Better Nights
Control-IQ+ is the only system with a dedicated Sleep Activity. Real-world data demonstrated a 90% overnight time in range.1
Better A1c
Control‑IQ+ is the only system with AutoBolus,† which helps deliver better A1c results, even if you sometimes miss meal boluses.2
Tandem Diabetes Care will contact you with additional information.
The Tandem t:slim mobile app connects to your pump, giving you the freedom to bolus from your compatible smartphone without touching your pump.‡

Best-In-Class Outcomes
The t:slim X2 insulin pump is the user-friendly system designed to help improve time in range.

Time in Range3§
According to real-world results.

Easy to Use4
According to study participants.
Tandem Diabetes Care has made a difference in not just my life, but in my family’s life. My mom used to come to school to give me insulin. Now that I have a t:slim X2 pump, I can just do it myself.
Jillian
diagnosed 2011


Ben Tzeel
MPH, RD, CSCS ◇


Madeleine
diagnosed 2013


Lauren Salko
Professional Freestyle Skier ◇

**Note:** Individual symptoms, situations, circumstances, and results may vary.
* Dexcom CGM sold separately.
† If glucose values are predicted to be above 10.0 mmol/L, Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value.
‡ Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, an app update, a remote software update on the t:slim X2 insulin pump, and additional training.
§ With optimized Correction Factor based on rule of less than 1600.
◇ Tandem Diabetes Care has compensation agreements with Lauren Salko and Ben Tzeel.
References
1. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601 608.
2. Akturk HK, et al. Diabetes Technol Ther. 2022;24(10):779-783.
3. Messer LH, Breton M. Diabetes Technol Ther. 2023;25(12):877-882.
4. Kudva YC, et al. Diabetes Technol Ther. 2021;23(10):673 683.
Important Safety Information
Always read the label and follow the instructions: tandemdiabetes.com/safetyinfo

